Oncolytics Insider Buy Signals Strong Confidence in Reovirus Pipeline and Nevada Shift
Oncolytics Biotech insider buying shows long‑term confidence in its reovirus platform, regulatory shift to Nevada, and patent expansion—signals to watch for future upside.
4 minutes to read